1. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy
   Yun-Hsuan Lin et al, 2018, Radiat Oncol CrossRef
2. Cost-effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin for first-line treatment of recurrent or metastatic nasopharyngeal carcinoma
   Xudong Chen et al, 2019, Oral Oncology CrossRef
3. The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan
   Kazumasa Komura et al, 2019, Ann Surg Oncol CrossRef
4. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio
   Wei Sun et al, 2016, Head Neck CrossRef
5. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio
   Mario Turri-Zanoni et al, 2017, Head Neck CrossRef
6. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma
   Li Su et al, 2017, Medicine CrossRef
7. Identifying pretreatment baseline factors predictive of distant metastasis in patients with nasopharyngeal carcinoma after radiotherapy
   Yu Wang et al, 2017, Medicine CrossRef
8. Elevated pretreatment platelet distribution width and platelet count predict poor prognosis in nasopharyngeal carcinoma
   XueCheng Xie et al, 2017, Oncotarget CrossRef
9. Pre-Treatment Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Occult Cervical Metastasis in Clinically Negative Neck Supraglottic and Glottic Cancer
   Giovanni Salzano et al, 2021, JPM CrossRef
10. MRI-based radiomics models can improve prognosis prediction for nasopharyngeal carcinoma with neoadjuvant chemotherapy
    Fan Zeng et al, 2022, Magnetic Resonance Imaging CrossRef
11. Establishment of a prognostic nomogram for patients with locoregionally advanced nasopharyngeal carcinoma incorporating clinical characteristics and dynamic changes in hematological and inflammatory markers
    Qin Liu et al, 2022, Front. Oncol. CrossRef
12. Platelet count and breast cancer stage
    Andi Fahdrin et al, 2023, BD CrossRef
13. Incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia in nasopharyngeal carcinoma
    Lu‐Lu Zhang et al, 2023, Cancer Medicine CrossRef
14. Elevated platelet count as a possible prognostic marker of survival in patients with head and neck tumours
    Zsuzsanna Szilasi et al, 2021, Orv Hetil CrossRef
15. PD‐L1 inhibitors combined with whole brain radiotherapy in patients with small cell lung cancer brain metastases: Real‐world evidence
    Litang Huang et al, 2024, Cancer Medicine CrossRef
16. A Nomogram Based on Platelet Distribution Width-to-Lymphocyte Ratio to Predict Overall Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
    Runzhi Wang et al, 2024, JIR CrossRef